Modern Care Journal

Published by: Kowsar

Seroprevalence and Risk Factors of Hepatitis E Among Women of Reproductive Age Residing in Birjand in 2016

Zohreh Azarkar 1 , * , Gholam Reza Sharifzadeh 2 , Mojtaba Sharifi Esfahani 1 and Nahid  Ghanbarzadeh 3
Authors Information
1 Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran
2 Social Determinants of Health Research Center, Birjand University of Medical Sciences, Birjand, Iran
3 Birjand University of Medical Sciences, Birjand, Iran
Article information
  • Modern Care Journal: 16 (1); e90029
  • Published Online: February 5, 2019
  • Article Type: Research Article
  • Received: January 29, 2019
  • Accepted: January 30, 2019
  • DOI: 10.5812/modernc.90029

To Cite: Azarkar Z, Sharifzadeh G R, Sharifi Esfahani M, Ghanbarzadeh N. Seroprevalence and Risk Factors of Hepatitis E Among Women of Reproductive Age Residing in Birjand in 2016, Mod Care J. Online ahead of Print ; 16(1):e90029. doi: 10.5812/modernc.90029.

Abstract
Copyright © 2019, Modern Care Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Abebe M, Ali I, Ayele S, Overbo J, Aseffa A, Mihret A. Seroprevalence and risk factors of hepatitis E virus infection among pregnant women in Addis Ababa, Ethiopia. PLoS One. 2017;12(6). e0180078. doi: 10.1371/journal.pone.0180078. [PubMed: 28650982]. [PubMed Central: PMC5484499].
  • 2. World Health Organization. Hepatitis E. 2018. Available from: http://wwwwhoint/news-room/fact-sheets/detail/hepatitis-e.
  • 3. Azarkar Z, Miri MR, Arjmand S. Investigating the seroprevalence of hepatitis E among blood donors referring to blood donation centers in Birjand county in Iran. Mod Care J. 2016;In Press. doi: 10.17795/modernc.9456.
  • 4. Mamani M, Zamani M, Hashemi SH, Keramat F. Seroprevalence of antibodies to hepatitis E virus among pregnant women. Avicenna J Clin Microb Infec. 2015;2(2). doi: 10.17795/ajcmi-25339.
  • 5. Azarkar Z, Ebrahimzadeh A, Sharifzadeh G, Ziaee M, Fereidouni M. Seroprevalence and risk factors of hepatitis E in eastern Iran. Iran Red Crescent Med J. 2017;20(S1). doi: 10.5812/ircmj.41644.
  • 6. Jahanbakhsh F, Bagheri Amiri F, Sedaghat A, Fahimfar N, Mostafavi E. Prevalence of HAV Ab, HEV (IgG), HSV2 IgG, and syphilis among sheltered homeless adults in Tehran, 2012. Int J Health Policy Manag. 2017;7(3):225-30. doi: 10.15171/ijhpm.2017.74. [PubMed: 29524951]. [PubMed Central: PMC5890067].
  • 7. Rasti M, Samarbafzadeh A, Neisi N, Makvandi M, Najafifard S, Sharifat M, et al. Study on the seroprevalence of hepatitis E virus infection in pregnant women referring to Imam Khomeini General Hospital in Ahvaz. Jentashapir J Health Res. 2014;5(3).
  • 8. Taherkhani R, Farshadpour F. Epidemiology of hepatitis E in pregnant women and children in Iran: A general overview. J Clin Transl Hepatol. 2016;4(3):269-76. doi: 10.14218/JCTH.2016.00013. [PubMed: 27777896]. [PubMed Central: PMC5075011].
  • 9. Alizadeh M, Rafeey M, Jafarabadi MA, Taghavi S, Sayyah-Melli M, Esmaili H. Sero-epidemiology and risk factors of hepatitis E among pregnant women in Tabriz, Iran. Int J Med Res Health Sci. 2016;5(4):224-7.
  • 10. Farshadpour F, Taherkhani R, Ravanbod MR, Eghbali SS, Taherkhani S, Mahdavi E. Prevalence, risk factors and molecular evaluation of hepatitis E virus infection among pregnant women resident in the northern shores of Persian Gulf, Iran. PLoS One. 2018;13(1). e0191090. doi: 10.1371/journal.pone.0191090. [PubMed: 29329329]. [PubMed Central: PMC5766211].
  • 11. Ehteram H, Ramezani A, Eslamifar A, Sofian M, Banifazl M, Ghassemi S, et al. Seroprevalence of hepatitis E virus infection among volunteer blood donors in central province of Iran in 2012. Iran J Microbiol. 2013;5(2):172-6. [PubMed: 23825737]. [PubMed Central: PMC3696855].
  • 12. Rostamzadeh Khameneh Z, Sepehrvand N, Khalkhali HR. Seroprevalence of hepatitis E among pregnant women in Urmia, Iran. Hepat Mon. 2013;13(11). e10931. doi: 10.5812/hepatmon.10931. [PubMed: 24348644]. [PubMed Central: PMC3858979].
  • 13. Moradi A, Besharat S, Minaiifar MM, Roshandel G, Tabaraii A. [Seroepidemiologic assessment of Hepatitis E virus in women of reproductive age, Gorgan]. Zahedan J Res Med Sci. 2010;12(1). Persian.
  • 14. Ataei B, Nokhodian Z, Javadi AA, Kassaian N, Shoaei P, Farajzadegan Z, et al. Hepatitis E virus in Isfahan province: A population-based study. Int J Infect Dis. 2009;13(1):67-71. doi: 10.1016/j.ijid.2008.03.030. [PubMed: 18599335].
  • 15. Hannachi N, Hidar S, Harrabi I, Mhalla S, Marzouk M, Ghzel H, et al. [Seroprevalence and risk factors of hepatitis E among pregnant women in central Tunisia]. Pathol Biol (Paris). 2011;59(5):e115-8. French. doi: 10.1016/j.patbio.2009.06.004. [PubMed: 19896306].
  • 16. Caron M, Kazanji M. Hepatitis E virus is highly prevalent among pregnant women in Gabon, central Africa, with different patterns between rural and urban areas. Virol J. 2008;5:158. doi: 10.1186/1743-422X-5-158. [PubMed: 19102767]. [PubMed Central: PMC2628354].
  • 17. Adjei AA, Tettey Y, Aviyase JT, Adu-Gyamfi C, Obed S, Mingle JA, et al. Hepatitis E virus infection is highly prevalent among pregnant women in Accra, Ghana. Virol J. 2009;6:108. doi: 10.1186/1743-422X-6-108. [PubMed: 19619291]. [PubMed Central: PMC2717077].
  • 18. Stoszek SK, Abdel-Hamid M, Saleh DA, El Kafrawy S, Narooz S, Hawash Y, et al. High prevalence of hepatitis E antibodies in pregnant Egyptian women. Trans R Soc Trop Med Hyg. 2006;100(2):95-101. doi: 10.1016/j.trstmh.2004.12.005. [PubMed: 16257426].
  • 19. Begum N, Devi SG, Husain SA, Ashok K, Kar P. Seroprevalence of subclinical HEV infection in pregnant women from north India: A hospital based study. Indian J Med Res. 2009;130(6):709-13. [PubMed: 20090131].
  • 20. Oncu S, Oncu S, Okyay P, Ertug S, Sakarya S. Prevalence and risk factors for HEV infection in pregnant women. Med Sci Monit. 2006;12(1):CR36-9. [PubMed: 16369469].
  • 21. Cevrioglu AS, Altindis M, Tanir HM, Aksoy F. Investigation of the incidence of hepatitis E virus among pregnant women in Turkey. J Obstet Gynaecol Res. 2004;30(1):48-52. [PubMed: 14718021].
  • 22. Irene Y, Vaneet K. HEV infection in pregnancy. J Obstet Gynecol India. 2006;56(1):146-8.
  • 23. Yasmeen T, Hashmi HA, Taj A. Fetomaternal outcome with hepatitis E in pregnancy. J Coll Physicians Surg Pak. 2013;23(10):711-4. doi: 10.2013/JCPSP.711714. [PubMed: 24112256].
  • 24. Navaneethan U, Al Mohajer M, Shata MT. Hepatitis E and pregnancy: Understanding the pathogenesis. Liver Int. 2008;28(9):1190-9. doi: 10.1111/j.1478-3231.2008.01840.x. [PubMed: 18662274]. [PubMed Central: PMC2575020].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments